ArticleBMJ open2026

Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study.

So-Hyeon Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.